Ryan Scott | Authors


Understanding irAEs Is Vital for IO Combo Use in HCC

October 05, 2021

In an interview with during the 2021 International Liver Cancer Association Annual Conference, David J. Pinato, MD discussed combination strategies in hepatocellular carcinoma, how to manage associated toxicities, and how safety profiles can help to inform treatment decisions for this patient population.